Report : Global Liquid Biopsy Market 2017-2021 is a new market research publication announced by Reportstack.
Report Outline: Like prostate cancer, other cancer cases such as lung cancer and breast cancer are increasing. To treat the disease at its early stage, liquid biopsies are performed, which helps in the detection of cancer. An increasing number of cancer cases will increase the need for liquid biopsy in the market. The skilled lab technicians are required to handle liquid biopsy systems such as polymerase chain reactions (PCRs) and assays. However, shortage of skilled physicians and lab technicians is one of the major challenges in the market. Lack of skilled technicians is a common challenge in hospitals and diagnostic laboratories in many developing and underdeveloped countries in APAC and the Sub-Saharan region. This will pose a major threat, as improper testing can lead to errors in the test results.
For detailed report with TOC, please click here Global Liquid Biopsy Market 2017-2021
Market Growth: The global liquid biopsy market to grow at a CAGR of 20.31% during the period 2017-2021.
Key vendors • Biocept
• Exosome Diagnostics
• QIAGEN
• Roche Molecular Diagnostics
• Exosome Diagnostics
• QIAGEN
• Roche Molecular Diagnostics
Other prominent vendors • AccuraGen
• Agena Bioscience
• Bio-Rad Laboratories
• CellMax Life
• Chronix Biomedical
• Clearbridge BioMedics
• Circulogene Theranostics
• Cynvenio Biosystems
• Epic Sciences
• Freenome
• Genomic Health
• Natera
• Novogene
• OncoCyte
• Pathway Genomics
• Personal Genome Diagnostics
• RainDance Technologies
• Sequenom
• Sysmex
• Thermo Fisher Scientific
• Transgenomic
• Vermillion
• WaveSense
• Agena Bioscience
• Bio-Rad Laboratories
• CellMax Life
• Chronix Biomedical
• Clearbridge BioMedics
• Circulogene Theranostics
• Cynvenio Biosystems
• Epic Sciences
• Freenome
• Genomic Health
• Natera
• Novogene
• OncoCyte
• Pathway Genomics
• Personal Genome Diagnostics
• RainDance Technologies
• Sequenom
• Sysmex
• Thermo Fisher Scientific
• Transgenomic
• Vermillion
• WaveSense
Regions Covered:
• Americas
• APAC
• EMEA
• APAC
• EMEA
Companies Mentioned
Biocept, Exosome Diagnostics, QIAGEN, Roche Molecular Diagnostics, AccuraGen, Agena Bioscience, Bio-Rad Laboratories, CellMax Life, Chronix Biomedical, Clearbridge BioMedics, Circulogene Theranostics, Cynvenio Biosystems, Epic Sciences, Freenome, Genomic Health, Natera, Novogene, OncoCyte, Pathway Genomics, Personal Genome Diagnostics, RainDance Technologies, Sequenom, Sysmex, Thermo Fisher Scientific, Transgenomic, Vermillion, and WaveSense
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###
No comments:
Post a Comment